Rapid Therapeutic Science Laboratories 

$0.01
5
-$0-14.29% Monday 20:48

Statistics

Day High
0.01
Day Low
0
52W High
0.01
52W Low
0
Volume
9,500
Avg. Volume
15,167
Mkt Cap
113,922
P/E Ratio
0.2
Dividend Yield
-
Dividend
-

Earnings

10NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.2
-0.13
-0.07
-0
Expected EPS
N/A
Actual EPS
-0.03

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-366,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RTSL. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Rapid Therapeutic Science Laboratories, Inc. operates as a biotech company. The company engages in the aerosol delivery of non-psychoactive cannabinoids to the blood stream for treatment of chronic pain, post-traumatic stress disorder, insomnia, surgery recovery, and other ailments. It offers pressurized meter dose inhaler, a device that delivers a measured amount of aerosolized inhalant in a mist to the lungs; sublingual oral spray devices; and water-soluble cannabidiol and cannabigerol isolates under the nhaler brand. The company was formerly known as Holly Brothers Pictures, Inc. and changed its name to Rapid Therapeutic Science Laboratories, Inc. in January 2020. Rapid Therapeutic Science Laboratories, Inc. was incorporated in 2013 and is based in Dallas, Texas. Rapid Therapeutic Science Laboratories, Inc. was a former subsidiary of Texas Mdi, Inc.
Show more...
CEO
Mr. Donal R. Schmidt Jr.
Employees
3
Country
US
ISIN
US7534312043

Listings

0 Comments

Share your thoughts

FAQ

What is Rapid Therapeutic Science Laboratories stock price today?
The current price of RTSL is $0.01 USD — it has decreased by -14.29% in the past 24 hours. Watch Rapid Therapeutic Science Laboratories stock price performance more closely on the chart.
What is Rapid Therapeutic Science Laboratories stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Rapid Therapeutic Science Laboratories stocks are traded under the ticker RTSL.
What is Rapid Therapeutic Science Laboratories market cap?
Today Rapid Therapeutic Science Laboratories has the market capitalization of 113,922
What were Rapid Therapeutic Science Laboratories earnings last quarter?
RTSL earnings for the last quarter are -0.03 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Rapid Therapeutic Science Laboratories revenue for the last year?
Rapid Therapeutic Science Laboratories revenue for the last year amounts to 0 USD.
What is Rapid Therapeutic Science Laboratories net income for the last year?
RTSL net income for the last year is -366,000 USD.
How many employees does Rapid Therapeutic Science Laboratories have?
As of April 02, 2026, the company has 3 employees.
In which sector is Rapid Therapeutic Science Laboratories located?
Rapid Therapeutic Science Laboratories operates in the Health Care sector.
When did Rapid Therapeutic Science Laboratories complete a stock split?
The last stock split for Rapid Therapeutic Science Laboratories was on March 31, 2022 with a ratio of 1:25.
Where is Rapid Therapeutic Science Laboratories headquartered?
Rapid Therapeutic Science Laboratories is headquartered in Dallas, US.